The specialty clinics segment held a 13% share of the market in 2025 and is expected to grow at a CAGR of 11.7% during the projection period
Sulfonylureas (Glipizide, Glyburide) Insulin secretion | Hypoglycemia, weight gain 3
The research suggests that approximately 22.4% of people on GLP-1 class medications develop nutritional deficiencies within 12 months, which is one reason regular blood monitoring is recommended throughout treatment
Since then, its slowly been emerging that they have another surprising effect: many users report less of a desire to throw back as many drinks as they did before starting the injections
REDEFINE2: Over 1,200 adults with T2DM and obesity/overweight achieved 15.7% weight loss after 68 weeks among adherent patients (3.1% with placebo)
Procedure : The Watchman device is inserted through a catheter into the left atrium, where it seals off the LAA